Targeted therapy can stop cancer cells from growing or spreading.

Targeted therapy is currently being studied for treatment of pancreatic cancer.

Instead there are targeted therapies which do not involve the removal of any organs or serious surgery.

There is virtually no data regarding new molecular targets or targeted therapy in the literature to date.

But targeted therapies, because they attack the underlying mechanisms of cancer more specifically, tend to have fewer side effects.

Targeted therapy may be considered the current pinnacle of advances spawned by such insights.

Clinical trials of chemotherapy and/or targeted therapy with a monoclonal antibody.

Targeted therapy with antiangiogenic agents are used to treat advanced renal cell cancer.

This avidity can assist in diagnosis and may make some tumors vulnerable to hormone targeted therapies.

Combination chemotherapy and targeted therapy with a monoclonal antibody.